Madison, WI - Memory Loss Improvement Study QB-0011 - Prevagen® Memory Study is being announced by Quincy Bioscience for Brain Awareness Week starting March 15th. The new Prevagen Memory Loss Study (http://prevagen.com/
Brain Awareness Week (http://www.dana.org/
The new memory loss study, being announced for BAW by Quincy Biosciences, will use the brain health supplement Prevagen having as its main ingredient a naturally occurring calcium-binding protein discovered in jellyfish called apoaequorin. Prevagen is the first and only product to use this active ingredient.
The study is a randomized placebo-controlled, double-blind study that will require five cognitive testing sessions during the three-month study period. The impact of Prevagen on brain cell protection will be evaluated using computer-based cognitive testing software by Cogstate, Ltd., a leading cognitive testing software company based in Melbourne, Australia.
“We are excited about the new Prevagen Memory Study. We are researching various areas in order to bring hope to people with different health challenges related to aging and memory with the goal of improving quality of life,” says Mark Underwood, Quincy Bioscience president. “Additionally, we are doing a series of educational radio shows during March Brain Awareness Week to help raise brain awareness.”
Photo:
http://www.prlog.org/




